NCT04894643 2026-03-20
PARC
EBG MedAustron GmbH
Phase NA Recruiting
Clinical Trials
8 trialsNCT07474103 2026-03-16
SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase NA Recruiting
NCT05838391 2026-02-03
Adaptive Radiation in Anal Cancer
Columbia University
Phase NA Recruiting
NCT05494190 2025-12-30
The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma
Eye & ENT Hospital of Fudan University
Phase NA Recruiting
NCT07156058 2025-09-04
MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Recruiting
NCT06894797 2025-03-25
Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.
Peking University Cancer Hospital & Institute
Phase NA Recruiting
NCT06349044 2024-08-27
A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.
Zhejiang Cancer Hospital
Phase NA Recruiting
NCT05877573 2023-07-05
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
Nanfang Hospital, Southern Medical University
Phase NA Recruiting